HOPE: A Trial of Hydroxichloroquine Plus Azithromycin in High Risk COVID-19
Status:
Withdrawn
Trial end date:
2020-10-30
Target enrollment:
Participant gender:
Summary
Multicenter, double blind, randomized clinical trial for high-risk patients over 18 years of
age, symptomatic for COVID-19 infection, without any severity criteria